Lebanon vs Netherlands: The number of people with susceptibility test result for rifampicin
Lebanon
228
in 2021
Netherlands
270
in 2021
Lebanon rank
91st
Netherlands rank
88th
The number of people with susceptibility test result for rifampicin over time
- Lebanon
- Netherlands
How they compare
Netherlands currently reports 270 against 228 in Lebanon, a difference of 42.
That makes Netherlands's figure about 1.2 times Lebanon's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Netherlands ahead.
Lebanon ranks 91st and Netherlands ranks 88th of 155 countries.
Lebanon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lebanon | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 331.33 | 322.33 | 9 | Lebanon |
| 2020s | 277.5 | 257 | 20.5 | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Lebanon or Netherlands?
- Netherlands, at 270 against 228 in Lebanon as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Lebanon and Netherlands?
- 42, with Netherlands ahead.
- How many years of comparable data are there for Lebanon and Netherlands?
- 5 years are reported by both, from 2017 to 2021.
- How do Lebanon and Netherlands rank globally for the number of people with susceptibility test result for rifampicin?
- Lebanon ranks 91st and Netherlands ranks 88th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.